Thromboprophylaxis Reduced Venous Thromboembolism in Sickle Cell Patients with Central Venous Access Devices: A Retrospective Cohort StudyStéphanie Forté, Kevin H.M. Kuo, John Aneke et al.|Journal of Clinical Medicine|2022Cited by 14
Is There a Role for Thromboprophylaxis in Sickle Cell Patients with Central Venous Access Devices?Stéphanie Forté, Kevin H.M. Kuo, Nafanta Fadiga et al.|Blood|2018Cited by 2
Validation of Sickle Cell Disease Severity Score in a Cohort of Hemoglobin SC Disease PatientsRebecca Marie Rosart, Kevin H.M. Kuo, Andrew Binding et al.|Blood|2018Cited by 1